REXTOVY Trademark

Trademark Overview

On Thursday, March 2, 2023, a trademark application was filed for REXTOVY with the United States Patent and Trademark Office. The USPTO has given the REXTOVY trademark a serial number of 97820173. The federal status of this trademark filing is REGISTERED as of Tuesday, July 15, 2025. This trademark is owned by AMPHASTAR PHARMACEUTICALS, INC.. The REXTOVY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists administered only by nasal spray; pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose administered only by nasal spray; Intranasal drug delivery devices, injector devices for nasal delivery, or devices for nasal delivery, all pre-filled with pharmaceuticals, namely, opioid antagonists and narcotic antagonists and pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose
rextovy

General Information

Serial Number97820173
Word MarkREXTOVY
Filing DateThursday, March 2, 2023
Status700 - REGISTERED
Status DateTuesday, July 15, 2025
Registration Number7868561
Registration DateTuesday, July 15, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, opioid antagonists and narcotic antagonists administered only by nasal spray; pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose administered only by nasal spray; Intranasal drug delivery devices, injector devices for nasal delivery, or devices for nasal delivery, all pre-filled with pharmaceuticals, namely, opioid antagonists and narcotic antagonists and pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 9, 2023
Primary Code005
First Use Anywhere DateTuesday, May 7, 2024
First Use In Commerce DateWednesday, August 7, 2024

Trademark Owner History

Party NameAMPHASTAR PHARMACEUTICALS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRancho Cucamonga, CA 91730
Party NameAMPHASTAR PHARMACEUTICALS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRancho Cucamonga, CA 91730
Party NameAMPHASTAR PHARMACEUTICALS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRancho Cucamonga, CA 91730

Trademark Events

Event DateEvent Description
Monday, May 15, 2023ASSIGNED TO EXAMINER
Monday, March 6, 2023NEW APPLICATION ENTERED
Wednesday, March 22, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 30, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, June 5, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, June 9, 2023EXAMINERS AMENDMENT -WRITTEN
Friday, June 9, 2023EXAMINERS AMENDMENT E-MAILED
Friday, June 9, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, June 9, 2023EXAMINER'S AMENDMENT ENTERED
Friday, June 9, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 28, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, August 10, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Thursday, January 11, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, January 25, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, February 12, 2024ASSIGNED TO PETITION STAFF
Tuesday, February 13, 2024POST PUBLICATION AMENDMENT - ENTERED
Tuesday, April 9, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 23, 2024USE AMENDMENT FILED
Thursday, May 23, 2024TEAS STATEMENT OF USE RECEIVED
Monday, July 1, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, July 29, 2024SU - NON-FINAL ACTION - WRITTEN
Monday, July 29, 2024NON-FINAL ACTION E-MAILED
Monday, July 1, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 29, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 4, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 8, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 8, 2024SOU EXTENSION 1 FILED
Tuesday, October 8, 2024SOU EXTENSION 1 GRANTED
Friday, March 14, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, May 6, 2025SU - FINAL REFUSAL - WRITTEN
Tuesday, June 24, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 15, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, July 15, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, July 16, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 6, 2025FINAL REFUSAL E-MAILED
Tuesday, May 6, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, June 24, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 24, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, June 25, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Related Keywords

rextovy antagonists nasal opioid narcotic preparations devices delivery drug pharmaceutical overdose